Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who european region, June 2013

Eurosurveillance

Volumn 19, Issue 40, 2014, Pages

  Pereyaslov, D ^a   Rosin, P ^b   Palm, D ^b   Zeller, H ^b   Gross, D ^a   Brown, C S ^a   Struelens, M J ^b   Robo, Alma ^c   Hatibi, Iris Hasibra ^c   Alis, Josep Casals ^d   Sargsyan, Shushan ^e   Gurbanov, Sadraddin ^f   Gribkova, Natalia ^g   Van Ranst, Marc ^h   Ieven, Greet ^h   Patteet, Sophie ^h   Tomic, Stanka ⁱ   Korsun, Neli ^j   Drazenovic, Vladimir ^k   Pieridou Bagkatzouni, Despo ^l   Jirincova, Helena ^m   Havlickova, Martina ^m   Fomsgaard, Anders ⁿ   Rae, KüLli ^o   Lappalainen, Maija ^p   Ikonen, Niina ^q   Lina, Bruno ^r   Van Der Werf, Sylvie ^s   Manuguerra, Jean Claude ^s   Machablishvili, Ann ^t   Eickmann, Markus ^u   Wolff, Thorsten ^v   Dobler, Gerhard ^w   Schmidt Chanasit, Jonas ^x   Drosten, Christian ^y   Papa, Anna ^z   Mentis, Andreas F ^aa   Kis, Zoltan ^ab   Löve, Arthur ^ac   Coughlan, Suzie ^ad   Mandelboim, Michal ^ae   Capobianchi, Maria R ^af   Landini, Maria Paola ^ag   Baldanti, Fausto ^ah   Palu, Giorgio ^ai   Ghisetti, Valeria ^aj   Donatelli, Isabella ^ak   Nusupbayeva, Gaukhar ^al   Tokhtabakiyeva, Zarina ^al   Kasymbekova, Kaliya ^am   Storozenko, Jelena ^an   Erne, Sabine ^ao   Griskevicius, Algirdas ^ap   Opp, Matthias ^aq   Barbara, Christopher ^ar   Vratnica, Zoran ^as   Reusken, Chantal ^at   Dudman, Susanne Gjeruldsen ^au   Hungnes, Olav ^au   Pancer, Katarzyna ^av   Guiomar, Raquel ^aw   Eder, Veronica ^ax   Lupulescu, Emilia ^ay   Yatsyshina, Svetlana ^az   Pisareva, Maria ^ba   Buzitskaya, Zhanna ^ba   Sergeev, Alexander ^bb   Nedeljković, Jasminka ^bc   Staroňová, Edita ^bd   Županc, Tatjana Avšič ^be   Petrovec, Miroslav ^be   Korva, Miša ^be   Prosenc, Katarina ^bf   Casas, Inmaculada ^bg,bh   Gaines, Hans ^bi   Cherpillod, Pascal ^bj   Zakirova, Niginamo ^bk   Bosevska, Golubinka ^bl   Altas, Basak ^bm   Ciblak, Meral ^bn,bo   Mironenko, Alla ^bp   Dykhanovska, Tetiana ^bq   Demchyshyna, Iryna ^bq   Bermingham, Alison ^br   Rakhimov, Ravshan ^bs   more..

^a WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c Institute of Public Health Albania   (Albania)

^d Government of Andorra   (Andorra)

^e Centre for Diseases Control and Prevention   (Armenia)

^f Anti Plague Station   (Azerbaijan)

^g Laboratory for Influenza and Influenza like Diseases Republican Research and Practical Center for Epidemiology and Microbiology   (United States)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ Public Health Institute of Republic of Srpska   (Bosnia and Herzegovina)

^j NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^k CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^l Microbiology Department Nicosia General Hospital   (United States)

^m NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

ⁿ STATENS SERUM INSTITUT   (Denmark)

^o Health Board   (Estonia)

^p HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^q NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^r Centre National de Réference Virus Influenza Région Sud   (France)

^s INSTITUT PASTEUR   (France)

^t National Center for Disease Control and Public Health   (Georgia)

^u PHILIPPS UNIVERSITY MARBURG   (Germany)

^v ROBERT KOCH INSTITUTE   (Germany)

^w Bundeswehr Instittue of Microbiology   (Germany)

^x BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^y UNIVERSITY OF BONN   (Germany)

^z ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^aa HELLENIC PASTEUR INSTITUTE   (Greece)

^ab NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^ac LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^ad UNIVERSITY COLLEGE DUBLIN   (Ireland)

^ae SHEBA MEDICAL CENTER   (Israel)

^af NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^ag UNIVERSITY OF BOLOGNA   (Italy)

^ah FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^ai UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^aj AMEDEO DI SAVOIA HOSPITAL   (Italy)

^ak National Influenza Centre Instituto Superiore di Sanita   (Italy)

^al National Reference Laboratory on Control of Viral Infections Scientifical Practical Center of Sanitary and Epidemiological Expertise and Monitoring   (Kazakhstan)

^am Centre of Molecular Genetic and Microbiological Investigations Department of State Sanitary Epidemiological Surveillance   (Kyrgyzstan)

^an RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^ao Office of Public Health Country Administration of Principality of Liechtenstein   (Liechtenstein)

^ap National Public Health Surveillance Laboratory   (Lithuania)

^aq LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^ar MATER DEI HOSPITAL   (Malta)

^as Institute of Public Health of Montenegro   (Montenegro)

^at NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^au NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^av NATIONAL MEDICINES INSTITUTE   (Poland)

^aw NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^ax National Center for Public Health   (Moldova)

^ay CANTACUZINO INSTITUTE   (Romania)

^az CENTRAL RESEARCH INSTITUTE OF EPIDEMIOLOGY   (Russian Federation)

^ba Smorodintsev Research Institute of Influenza WHO National Influenza Centre of Russia   (Russian Federation)

^bb STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^bc Biomedical Center Institute Torlak   (Serbia)

^bd Department of Environment and Health   (Slovakia)

^be UNIVERSITY OF LJUBLJANA   (Slovenia)

^bf National Public Health Institute   (Slovenia)

^bg INSTITUTO DE SALUD CARLOS III   (Spain)

^bh HOSPITAL DE BASURTO   (Spain)

^bi Swedish Institute for Communicable Disease Control   (Sweden)

^bj GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^bk Virology Laboratory State Sanitary Epidemiological Surveillance Dushanbe The Former Yugoslav Republic of Macedonia   (Tajikistan)

^bl Laboratory for Virology and Molecular Diagnostics Institute of Public Health   (Tajikistan)

^bm National Influenza Centre Virology Reference and Research Laboratory Public Health Institutions of Turkey   (Turkey)

^bn ISTANBUL UNIVERSITY   (Turkey)

^bo Central Reference Laboratory Sanitary Epidemiologic Service   (Turkmenistan)

^bp National Influenza Centre LV Gromashevsky Institute of Epidemiology and Infectious Diseases NAMS   (Ukraine)

^bq Central Sanitary and Epidemiological Station   (Ukraine)

^br PUBLIC HEALTH ENGLAND   (United Kingdom)

^bs National Influenza Centre Institute of Virology   (Uzbekistan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RECOMBINANT PROTEIN; VIRUS RNA;

ARTICLE; CORONAVIRUS INFECTION; DISEASE SURVEILLANCE; EUROPE; HEALTH CARE PLANNING; HEALTH SURVEY; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; SEROLOGY; WESTERN BLOTTING; WORLD HEALTH ORGANIZATION; COMMUNICABLE DISEASE; CORONAVIRUS INFECTIONS; EUROPEAN UNION; GENETICS; ISOLATION AND PURIFICATION; LABORATORY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PROCEDURES; SENTINEL SURVEILLANCE; SEQUENCE ANALYSIS; STANDARD; STANDARDS; VIROLOGY;

COMMUNICABLE DISEASES, EMERGING; CORONAVIRUS INFECTIONS; EUROPEAN UNION; HEALTH SURVEYS; HUMANS; LABORATORIES; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENTINEL SURVEILLANCE; SEQUENCE ANALYSIS; WORLD HEALTH ORGANIZATION;

EID: 84908032847     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.40.20923     Document Type: Article

References (26)

1. van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012;3(6):pii=e00473-12. http://dx.doi.org/10.1128/mBio.00473-12. PMID:23170002
2. de Groot RJ, Baker SC, Baric R., Brown CS, Drosten C, Enjuanes L, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013;87(14):7790-2. http://dx.doi.org/10.1128/JVI.01244-13. PMID:23678167
3. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011;81:85-164. http://dx.doi.org/10.1016/B978-0-12-385885-6.00009-2. PMID:22094080
4. Bolles M, Donaldson E, Baric R. SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission. Curr Opin Virol. 2011;1(6):624-34. http://dx.doi.org/10.1016/j.coviro.2011.10.012. PMID:22180768
5. van der Hoek L. Human coronaviruses: what do they cause? Antivir Ther. 2007;12(4 Pt B):651-8.PMID:17944272
6. Lau YL, Peiris JS. Pathogenesis of severe acute respiratory syndrome. Curr Opin Immunol. 2005;17(4):404-10. http://dx.doi.org/10.1016/j.coi.2005.05.009. PMID:15950449
7. World Health Organization (WHO). Global alert and response. Middle East respiratory syndrome coronavirus (MERS-CoV) – update. Geneva: WHO; 21 July 2013. Available from: http://www.who.int/csr/don/2013_07_21/en/index.html
8. European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). Stockholm: ECDC; 22 July 2013. Available from: http://www.ecdc.europa.eu/en/publications/Publications/RRA-ECDC-MERS-CoV-Sixth-update.pdf
9. World Health Organization (WHO). Laboratory testing for Middle East respiratory syndrome coronavirus. Interim recommendations. Geneva: WHO; September 2013 Available from: http://www.who.int/csr/disease/coronavirus_infections/MERS_Lab_recos_16_Sept_2013.pdf
10. Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17(39):pii=20285. PMID:23041020
11. Corman VM, Müller MA, Costabel U, Timm J, Binger T, Meyer B, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012;17(49):pii= 20334. PMID:23231891
12. World Health Organization (WHO). Revised interim case definition for reporting to WHO – Middle East respiratory syndrome coronavirus (MERS-CoV). Geneva: WHO; 3 July 2013. Available from: http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/index.html
13. World Health Organization (WHO). Interim surveillance recommendations for human infection with novel coronavirus –update. Geneva: WHO; 18 May 2013. Available from: http://www.who.int/csr/disease/coronavirus_infections/InterimRevisedSurveillanceRecommendations_ nCoVinfection_18May13.pdf
14. European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). Stockholm: ECDC; 17 May 2013. Available from: http://ecdc.europa.eu/en/publications/Publications/risk-assessment-middle-east-respiratory-syndrome-coronavirus-MERS-CoV-17-may-2013.pdf
15. Pebody RG, Nicoll A, Buchholz U, Zambon M, Mounts A. Enhanced surveillance and investigation of coronavirus: what is required? East Mediterr Health J. 2013;19(Suppl 1):S55-60.PMID:23888796
16. Palm D, Pereyaslov D, Vaz J, Broberg E, Zeller H, Gross D, et al.; Joint ECDC-WHO Regional Office for Europe Novel Coronavirus Laboratory Survey participants; ECDC National Microbiology Focal Points; WHO European Region EuroFlu Network; European Network for Diagnostics of “Imported” Viral Diseases (ENIVD). Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012. Euro Surveill. 2012;17(49):pii=20335.PMID:23231892
17. Buchholz U, Müller MA, Nitsche A, Sanewski A, Wevering N, Bauer-Balci T, et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill. 2013;18(8):pii=20406.PMID:23449231
18. Reusken C, Mou H, Godeke GJ, van der Hoek L, Meyer B, Müller MA, et al. Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill. 2013;18(14):20441. http://dx.doi.org/10.2807/1560-7917.ES2013.18.14.20441. PMID:23594517
19. Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, Sack S, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013;13(9):745-51. http://dx.doi.org/10.1016/S1473-3099(13)70154-3. PMID:23782859
20. Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, et al.; MERS-CoV study group. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013;381(9885):2265-72. http://dx.doi.org/10.1016/S0140-6736(13)60982-4. PMID:23727167
21. European Centre for Disease Prevention and Control (ECDC). Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). Updated rapid risk assessment. Stockholm: ECDC; 21 August 2014. Available from: http://www.ecdc.europa.eu/en/publications/Publications/Middle-East-respiratory-syndrome-coronavirus-Saudi%20Arabia-Qatar-Jordan-Germany-United-Kingdom.pdf
22. European Centre for Disease Prevention and Control (ECDC). Epidemiological update: Middle East respiratory syndrome coronavirus (MERS-CoV). Stockholm: ECDC; 1 October 2014. Available from: http://www.ecdc.europa.eu/en/press/news/_layouts/forms/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568&ID=1074
23. World Health Organization (WHO). Laboratory testing for Middle East respiratory syndrome coronavirus. Interim recommendations (revised). Geneva: WHO; September 2014. Available from: http://www.who.int/csr/disease/coronavirus_infections/WHO_interim_recommendations_lab_detection_ MERSCoV_092014.pdf?ua=1
24. World Health Organization (WHO). Interim surveillance recommendations for human infection with Middle East respiratory syndrome coronavirus. Geneva: WHO. 14 July 2014. Available from: http://www.who.int/csr/disease/coronavirus_infections/InterimRevisedSurveillanceRecommendations_CoVinfection_14July2014.pdf?ua=1
25. World Health Organization (WHO). Revised interim case definition for reporting to WHO – Middle East respiratory syndrome coronavirus (MERS-CoV). Geneva: WHO; 14 July 2014. Available from: http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/
26. World Health Organization (WHO). WHO statement on the second meeting of the IHR emergency committee concerning MERS-CoV. Geneva: WHO; 17 July 2013. Available from: http://www.who.int/mediacentre/news/statements/2013/mers_ cov_20130717/en/index.html